Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer

BACKGROUND: Phosphoglycerate kinase-1 (PGK1) has been recently documented in various malignancies; however, the molecular mechanisms of the variable PGK1 expression and its clinical significance in terms of survival status remain unclear. METHODS: Real-time quantitative PCR (real-time qPCR) and west...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, S, Liang, X, Zhang, X, Liu, T, Shi, Q, Song, Y, Jiang, Y, Wu, H, Lu, X, Pang, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402453/
https://www.ncbi.nlm.nih.gov/pubmed/25867275
http://dx.doi.org/10.1038/bjc.2015.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402453/
https://www.ncbi.nlm.nih.gov/pubmed/25867275
http://dx.doi.org/10.1038/bjc.2015.114

Ejemplares similares